Filing Details
- Accession Number:
- 0000899243-22-014551
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-04-12 16:07:18
- Reporting Period:
- 2022-04-08
- Accepted Time:
- 2022-04-12 16:07:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1334365 | Yuchun Lee | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-04-08 | 2,000 | $81.54 | 3,875 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-04-08 | 418 | $276.62 | 3,457 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-04-08 | 430 | $277.29 | 3,027 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-04-08 | 700 | $279.36 | 2,327 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-04-08 | 452 | $280.37 | 1,875 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-04-11 | 2,000 | $81.54 | 3,875 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-04-11 | 922 | $279.81 | 2,953 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-04-11 | 968 | $280.62 | 1,985 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-04-11 | 110 | $281.58 | 1,875 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2022-04-08 | 2,000 | $0.00 | 2,000 | $81.54 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2022-04-11 | 2,000 | $0.00 | 2,000 | $81.54 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 10,000 | 2023-05-31 | No | 4 | M | Direct | |
| 8,000 | 2023-05-31 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1.
- Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $276.62 (range $276.08 to $276.81).
- Open market sales reported on this line occurred at a weighted average price of $277.29 (range $277.16 to $277.46).
- Open market sales reported on this line occurred at a weighted average price of $279.36 (range $278.86 to $279.74).
- Open market sales reported on this line occurred at a weighted average price of $280.37 (range $280.06 to $281.02).
- Open market sales reported on this line occurred at a weighted average price of $279.81 (range $279.29 to $280.18).
- Open market sales reported on this line occurred at a weighted average price of $280.62 (range $280.31 to $281.28).
- Open market sales reported on this line occurred at a weighted average price of $281.58 (range $281.55 to $281.58).
- Fully vested.
Billionaire Hedge Funds
